pharma · Early Childhood Caries · Acute Myeloid Leukemia
University of Hong
The University of Hong Kong
University of Hong clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CN
- Programs
- 42
- Drugs
- 71
- Patents
- 0
University of Hong projects
13 ClinicalTrials.gov programs sponsored by University of Hong.
University of Hong has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Alcohol injection
The University of Hong Kong
Malignancy
1 trial -
Atosiban
The University of Hong Kong
Subfertility
1 trial -
Brolucizumab
The University of Hong Kong
Age-Related Macular Degeneration
1 trial -
Bupivacaine Injection [Marcaine]
The University of Hong Kong
Acute Pain
1 trial -
Cinacalcet
The University of Hong Kong
Kidney Failure
1 trial -
Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy
The University of Hong Kong
Fontan
1 trial -
Dexamethasone
The University of Hong Kong
Total Knee Replacement
1 trial -
Dexmedetomidine
The University of Hong Kong
Anxiety, Separation
1 trial -
Ivabradine + Usual Care
The University of Hong Kong
Atrial Fibrillation (Permanent)
1 trial -
Oral hygiene intervention
The University of Hong Kong
Acute Stroke
1 trial -
Paracetamol
The University of Hong Kong
Influenza
1 trial -
Rivaroxaban 2.5 MG Oral Tablet [Xarelto]
The University of Hong Kong
Atherosclerosis, Coronary
1 trial -
Trivalent live attenuated seasonal influenza vaccine
The University of Hong Kong
Influenza Virus Infection
1 trial
Frequently asked questions
How many clinical projects does University of Hong have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.